Therapeutic Advances in Prostate Cancer
Presented by Robert Dreicer, MD, MS, MACP, FASCO, and Morgane C. Diven, PharmD, BCOP
University of Virginia, Charlottesville, Virginia; and Phoenix VA Health Care System, Phoenix, Arizona
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2019;10(3):272–274 |
© 2019 Harborside™
Robert Dreicer, MD, MS, MACP, FASCO, and Morgane C. Diven, PharmD, BCOP, discussed the emerging data regarding the role of genomics in metastatic castration-sensitive and -resistant prostate cancer, as well as strategies to manage the toxicities of current and emerging treatments for advanced prostate cancer.
For access to the full length article, please sign in